Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
11/01/2012 | US20120277451 Diacylglycerol acyltransferase genes and use thereof |
11/01/2012 | US20120277419 Method for manufacturing pegylated oligonucleotides |
11/01/2012 | US20120277418 Algal Elongases |
11/01/2012 | US20120277417 Algal desaturases |
11/01/2012 | US20120277413 Dendritic Cell Marker BDCA-2 Protein Sequence |
11/01/2012 | US20120277290 Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg |
11/01/2012 | US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification |
11/01/2012 | US20120277287 Modulating the CDC14B-CDH1-PLK1 Axis and Methods for Sensitizing Target Cells to Apoptosis |
11/01/2012 | US20120277285 Control of gene expression |
11/01/2012 | US20120277284 Modulation of signal transducer and activator of transcription 3 (stat3)expression |
11/01/2012 | US20120277282 Polynucleotides for use in medicine |
11/01/2012 | US20120277180 Cofactors and Methods for Use for Individuals |
11/01/2012 | US20120277144 Novel compounds for modulating neovascularisation and methods of treatment using these compounds |
11/01/2012 | US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
11/01/2012 | US20120277113 Array-based proximity ligation association assays |
11/01/2012 | US20120276646 Methods and reagents for analyzing riboswitches using fret |
11/01/2012 | US20120276627 Synthetic mimics of mir-124 |
11/01/2012 | US20120276600 Process For Preparing Dipeptidyl Peptidase IV Inhibitors And Intermediates Therefor |
11/01/2012 | US20120276590 Recombinant silkworm and silkworm protein comprising heterologous protein produced by the recombinant silkworm |
11/01/2012 | US20120276547 Aptamers selected against live s. pyogenes cells |
11/01/2012 | US20120276536 Hair Shape Susceptibility Gene |
11/01/2012 | US20120276535 Method for the diagnosis of limbal stem cell deficiency |
11/01/2012 | US20120276534 Probe for Detecting Polymorphism in Exon 12 of NPM1 Gene and Use Thereof |
11/01/2012 | US20120276533 Method for Simultaneously Detecting Polymorphisms of Acetaldehyde Dehydrogenase 2 and Alcohol Dehydrogenase 2 |
11/01/2012 | US20120276524 Genotyping method |
11/01/2012 | US20120276147 Ctsp cancer-testis antigens |
11/01/2012 | US20120276142 Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same |
11/01/2012 | US20120276136 Chemically programmable immunity |
11/01/2012 | US20120276128 HIV Envelope-CD4 Complexes and Hybrids |
11/01/2012 | US20120276120 T-Cell Stimulating Protein B and Methods of Use |
11/01/2012 | US20120276116 Prevention and Treatment of Amyloidogenic Disease |
11/01/2012 | US20120276115 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof |
11/01/2012 | US20120276076 Arf6 as a new target for treating alzheimer's disease |
11/01/2012 | US20120276072 Constructs for expressing lysosomal polypeptides |
11/01/2012 | US20120276071 Anti-HIV Group I Introns and Uses Thereof in Treating HIV Infections |
11/01/2012 | US20120272868 Production of graphene nanoribbons with controlled dimensions and crystallographic orientation |
11/01/2012 | CA2834291A1 Methods and compositions for nucleic acid analysis |
10/31/2012 | EP2518161A1 Method for detection of mutant alleles |
10/31/2012 | EP2518150A2 5'Triphosphate oligonucleotide with blunt end and uses thereof |
10/31/2012 | EP2517723A1 Compositions and methods of enhancing immune responses |
10/31/2012 | EP2516679A1 Tsg primer target detection |
10/31/2012 | EP2516664A1 Recombinant butyrylcholinesterases and truncates thereof |
10/31/2012 | CN102762744A Tsg primer target detection |
10/30/2012 | US8299322 Polypeptides having xylanase activity and polynucleotides encoding same |
10/30/2012 | US8299321 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
10/30/2012 | US8299320 Modulating plant carbon levels |
10/30/2012 | US8299238 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals |
10/30/2012 | US8299237 Nucleic acid sequences comprising NF-κB binding site within O(6)-methylguanine-DNA-methyltransferase (MGMT) promoter region and uses thereof for the treatment of cancer and immune-related disorders |
10/30/2012 | US8299236 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells |
10/30/2012 | US8299235 RNA molecules and vectors for gene silencing |
10/30/2012 | US8299234 siRNA hat inhibits WT1 gene expression and uses thereof |
10/30/2012 | US8299233 Molecular in vitro diagnosis of breast cancer |
10/30/2012 | US8299232 Constructing a DNA chimera for vaccine development against leishmaniasis and tuberculosis |
10/30/2012 | US8299230 Nucleic acid molecules encoding antibodies that bind cell-associated CA 125/O772P |
10/30/2012 | US8299229 Mucin antigen vaccine |
10/30/2012 | US8299228 Expression of Class 2 mannosidase and Class III mannosidase in lower eukaryotic cells |
10/30/2012 | US8299227 Method of immobilizing and stretching a nucleic acid on a substrate |
10/30/2012 | US8299226 2-nitrobenzyl-modified ribonucleotides |
10/30/2012 | US8299225 Amidite for synthesizing modified nucleic acid and method for synthesizing modified nucleic acid |
10/30/2012 | US8299211 Peptides and regulation of calcium channels |
10/30/2012 | US8299044 Apoptosis inducer for cancer cell |
10/30/2012 | US8299040 Treating cell proliferative disorders using antisense and/or RNA interfering agents; suppression of protein kinase C and/or transferase activity |
10/30/2012 | US8299039 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
10/30/2012 | US8298836 For forming an immune complex with an antigen in an analytical sample and being modified by adding an amino acid sequence comprising a charged amino acid residue and by being labeled with a fluorescent dye |
10/30/2012 | US8298821 p185neu-encoding DNA and therapeutical uses thereof |
10/30/2012 | US8298820 Influenza nucleic acid molecules and vaccines made therefrom |
10/30/2012 | US8298812 Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporters |
10/30/2012 | US8298807 Micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design |
10/30/2012 | US8298803 Polypeptides having arabinofuranosidase activity and polynucleotides encoding same |
10/30/2012 | US8298802 BGL3 beta-glucosidase and nucleic acids encoding the same |
10/30/2012 | US8298799 Hydrolases, nucleic acids encoding them and methods for making and using them |
10/30/2012 | US8298797 Δ-9 elongases and their use in making polyunsaturated fatty acids |
10/30/2012 | US8298792 Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators |
10/30/2012 | US8298788 Using transgenic escherichia as bioreactor for producing immunoglobulins specific to streptococcal capsular protein for use in treatment and prevention of bacterial infection |
10/30/2012 | US8298785 Use of ribozymes in the detection of adventitious agents |
10/30/2012 | US8298767 Compositions and methods for intramolecular nucleic acid rearrangement |
10/30/2012 | US8298764 Selection method for cell internalizing nucleic acids |
10/30/2012 | US8298761 Oligonucleotide sequences for use in diagnosing herpes simplex virus (HSV) infection |
10/30/2012 | US8298542 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia |
10/30/2012 | CA2671351C Compounds and methods for synthesis and purification of oligonucleotides |
10/30/2012 | CA2525184C Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses |
10/30/2012 | CA2505254C Universal tag assay |
10/26/2012 | WO2012145697A1 Modulation of hepatitis b virus (hbv) expression |
10/26/2012 | WO2012145676A1 Polypeptides and bacteriophages specific to klebsiella pneumoniae capsular type strains |
10/26/2012 | WO2012145674A1 Modulation of hepatitis b virus (hbv) expression |
10/26/2012 | WO2012145507A2 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies |
10/26/2012 | WO2012094492A3 Combinatorial dna taggants and methods of preparation and use thereof |
10/26/2012 | WO2012078536A3 Double stranded oligonucleotide compounds comprising threose modifications |
10/26/2012 | CA2833766A1 Modulation of hepatitis b virus (hbv) expression |
10/26/2012 | CA2833643A1 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies |
10/25/2012 | US20120272407 Compositions and methods for altering tocotrienol content |
10/25/2012 | US20120272403 Genetic transformation of jatropha curcas |
10/25/2012 | US20120272402 Corn event mir162 |
10/25/2012 | US20120272345 Diagnosis marker, diagnosis method and therapeutic agent for amyotrophic lateral sclerosis, and animal model and cell model developing amyotrophic lateral sclerosis |
10/25/2012 | US20120271043 Process and device for collecting nucleic acids of microorganisms from a particulate sample |
10/25/2012 | US20120271042 Method for isolation of genomic dna, rna and proteins from a single sample |
10/25/2012 | US20120271039 Method for purifying active gla-domain coagulation proteins |
10/25/2012 | US20120270930 Methods and compositions for dysferlin exon-skipping |
10/25/2012 | US20120270928 Microrna compounds and methods for modulating mir-21 activity |
10/25/2012 | US20120270925 Antisense molecules and methods for treating pathologies |